Research.Patient.info
not applicable (submitted trial is a bioequivalence in healthy subjects) research hub
2 indexed studies · 0 currently recruiting
- ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
Randomized, open-label, single dose, two-period, two-treatment, cross-over bioequivalence study comparing test product Rivaroxaban/Acetylsalicylic acid, tablet, 2.5 mg/50 mg (given as two tablets) to reference product Xarelto 2.5 mg film-coated tablets (given as two tablets) and Aspirin® N 100 mg tablet in healthy male and female subjects under fasting conditions.
This study compares a new combination medicine containing rivaroxaban and aspirin with existing separate medicines. We want to see if they act the same way in healthy adults. It's a quick, single-dose study for research purposes, not about treating an illness.
Czechia - ongoing, recruitingHuman Pharmacology (Phase I)- Bioequivalence Study
The pivotal bioequivalence study comparing the test product to the reference product, which belong to the group of medicines used in treatment of uncomplicated lower urinary tract infections.
This study is testing a new version of a common medicine for bladder infections in healthy volunteers. It checks if the new version works in the same way as the original to make sure it's just as safe and effective.
Czechia